Article Versions Notes

Rossi A, Lucarini V, Macchia I, Sestili P, Buccione C, Donati S, Ciccolella M, Sistigu A, D’Urso MT, Pacca AM, et al. Tumor-Intrinsic or Drug-Induced Immunogenicity Dictates the Therapeutic Success of the PD1/PDL Axis Blockade. Cells. 2020; 9(4):940. https://doi.org/10.3390/cells9040940

Rossi, Alessandra, Valeria Lucarini, Iole Macchia, Paola Sestili, Carla Buccione, Simona Donati, Maria Ciccolella, Antonella Sistigu, Maria Teresa D’Urso, Anna Maria Pacca, and et al. 2020. "Tumor-Intrinsic or Drug-Induced Immunogenicity Dictates the Therapeutic Success of the PD1/PDL Axis Blockade" Cells 9, no. 4: 940. https://doi.org/10.3390/cells9040940

Rossi, A., Lucarini, V., Macchia, I., Sestili, P., Buccione, C., Donati, S., Ciccolella, M., Sistigu, A., D’Urso, M. T., Pacca, A. M., Cardarelli, E., Mattei, F., Proietti, E., Schiavoni, G., & Bracci, L. (2020). Tumor-Intrinsic or Drug-Induced Immunogenicity Dictates the Therapeutic Success of the PD1/PDL Axis Blockade. Cells, 9(4), 940. https://doi.org/10.3390/cells9040940